Overdose Deaths Fall: Why We Can’t Accept 72,000 Annual Fatalities

A Diminishing, But Still Devastating, Toll

The numbers are trending in the right direction, but a recent report reveals a sobering reality: even with a significant drop in drug overdose deaths, the United States is still losing approximately 72,000 people each year to this crisis. Provisional data through late 2025 projects this figure, a decrease from roughly 110,000 in 2023 and 80,000 in 2024 according to the Centers for Disease Control and Prevention. While the 27% decline in 2024 is cause for cautious optimism, framing this as “unprecedented progress” risks obscuring a deeply troubling truth: we are becoming accustomed to a level of loss that, just a decade ago, would have been unthinkable.

As an addiction researcher and someone in long-term recovery, the initial relief at seeing the numbers fall was palpable. But the celebration feels premature when considering the scale of the ongoing tragedy. More than 81 lives lost every day – that’s the CDC’s framing of the improvement. But it’s a statistic that demands pause, not just applause.

Echoes of Past Progress, and Stalled Momentum

This pattern – a period of initial success followed by stagnation – isn’t new. It mirrors the history of efforts to combat drunk driving. In 1982, around 21,000 Americans died in alcohol-impaired crashes. The public outcry was immediate and forceful, leading to significant policy changes like raising the drinking age to 21 and implementing sobriety checkpoints. Deaths plummeted by nearly 50% by the mid-1990s. But, progress stalled after that. Further reductions would have required politically challenging structural changes – expanding public transit, increasing alcohol taxes, or mandating ignition interlocks – which were never fully implemented. For the past three decades, between 10,000 and 13,000 Americans have died annually in drunk driving crashes, a number largely accepted as an unavoidable consequence of modern life according to the National Highway Traffic Safety Administration.

The risk is that we are heading toward a similar “stable floor” with drug overdose deaths. The current decline, while welcome, could be misinterpreted as a sign that the crisis is over, leading to complacency and a rollback of critical resources. In 2017, a public health emergency was declared when the overdose toll reached roughly 70,000 as reported by the Government Accountability Office. When the number surpassed 100,000 in 2021, there was renewed urgency and funding. Now, with numbers returning to that earlier range, the narrative is shifting towards relief rather than sustained action.

Decelerating Progress and Concerning Policy Shifts

The rate of decline is already slowing. While 2024 saw a 27% drop in overdose deaths, provisional data for 2025 indicates a roughly 19% year-over-year decline, with some states even reporting increases according to the CDC. More alarmingly, policymakers are already dismantling some of the infrastructure that’s driving this progress. Last year, the White House withheld approximately $140 million in CDC grants dedicated to local overdose tracking and prevention, and also implemented staffing cuts at the agency’s injury prevention center as reported by WGBH.

The proposed federal budget cuts for fiscal year 2026 further threaten to undermine these efforts, with deeper cuts planned for the CDC and the Substance Abuse and Mental Health Services Administration as outlined in the HHS budget proposal. Defunding overdose surveillance, treatment, and harm reduction programs at a time when they are demonstrably effective is a clear signal of normalization.

Beyond the Numbers: The Importance of Sustained Investment

Some argue that concerns about stagnation are premature, given that numbers are still falling. However, this perspective misses the point. Normalization doesn’t begin when progress stops. it begins when progress is used to justify disengagement and a refusal to address the underlying challenges. The drunk driving movement faltered when 10,000 annual deaths became an accepted price of mobility.

The technologies currently contributing to the overdose decline – widespread naloxone distribution, expanded access to medications for opioid leverage disorder, fentanyl test strips, and data-driven surveillance – are effective, but only if they are consistently funded, distributed, and politically supported. It remains to be seen whether this decline will prompt sustained investment or political complacency.

What’s Next: Vigilance and Advocacy

The critical question isn’t whether 72,000 deaths is better than 110,000. It is. The real question is whether 72,000 deaths is acceptable. And if not, will 52,000 be? Until we confront this question directly, the answer will be written for us, incrementally, through the same quiet arithmetic that has allowed 10,000 drunk driving deaths to persist for decades. Continued vigilance, advocacy for sustained funding, and a refusal to accept any level of loss as inevitable are essential to bending the curve further and ultimately saving lives.

Wayne Kepner, Ph.D., M.P.H., is a postdoctoral fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. His research focuses on addiction health services and policy.